DK2800571T3 - Oromukosale flydende østradiolsammensætninger - Google Patents

Oromukosale flydende østradiolsammensætninger Download PDF

Info

Publication number
DK2800571T3
DK2800571T3 DK13700206.9T DK13700206T DK2800571T3 DK 2800571 T3 DK2800571 T3 DK 2800571T3 DK 13700206 T DK13700206 T DK 13700206T DK 2800571 T3 DK2800571 T3 DK 2800571T3
Authority
DK
Denmark
Prior art keywords
oromukosal
liquid
estradiol
compositions
estradiol compositions
Prior art date
Application number
DK13700206.9T
Other languages
English (en)
Inventor
Franciscus Wilhelmus Henricus Maria Merkus
Original Assignee
Innotesto Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innotesto Bvba filed Critical Innotesto Bvba
Application granted granted Critical
Publication of DK2800571T3 publication Critical patent/DK2800571T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK13700206.9T 2012-01-04 2013-01-04 Oromukosale flydende østradiolsammensætninger DK2800571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1200062.6A GB201200062D0 (en) 2012-01-04 2012-01-04 Estradiol oromucosal liquid compositions
PCT/EP2013/050110 WO2013102665A1 (en) 2012-01-04 2013-01-04 Oromucosal liquid estradiol compositions

Publications (1)

Publication Number Publication Date
DK2800571T3 true DK2800571T3 (da) 2016-10-24

Family

ID=45755705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13700206.9T DK2800571T3 (da) 2012-01-04 2013-01-04 Oromukosale flydende østradiolsammensætninger

Country Status (10)

Country Link
US (2) US9402811B2 (da)
EP (1) EP2800571B1 (da)
CN (1) CN104105487A (da)
AU (1) AU2013207215B2 (da)
BR (1) BR112014016510A8 (da)
CA (1) CA2861141A1 (da)
DK (1) DK2800571T3 (da)
ES (1) ES2595434T3 (da)
GB (1) GB201200062D0 (da)
WO (1) WO2013102665A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801670A (nl) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5073374A (en) 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
JPH06321771A (ja) 1992-07-31 1994-11-22 Tanabe Seiyaku Co Ltd 経皮投与用基剤
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US5955098A (en) 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
ES2234010T3 (es) * 1996-04-12 2005-06-16 Novadel Pharma Inc. Aerosol bucal polar.
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
WO2005041943A1 (en) * 2003-10-23 2005-05-12 Cipla Limited Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle
CN1882340A (zh) 2003-11-19 2006-12-20 艾克若克斯Dds有限公司 用于治疗或预防淀粉样变性病的方法和组合物
WO2007124250A2 (en) * 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
EP1867321A3 (en) 2006-06-07 2008-11-19 Familplan Consulting Ltd. A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent
AR068408A1 (es) 2007-09-14 2009-11-18 Drugtech Corp Pulverizacion de hormonas transdermicas
CA2714340A1 (en) 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend

Also Published As

Publication number Publication date
AU2013207215B2 (en) 2017-10-26
WO2013102665A1 (en) 2013-07-11
EP2800571A1 (en) 2014-11-12
US20160256473A1 (en) 2016-09-08
CN104105487A (zh) 2014-10-15
BR112014016510A2 (pt) 2017-06-13
AU2013207215A1 (en) 2014-07-24
CA2861141A1 (en) 2013-07-11
ES2595434T3 (es) 2016-12-30
US9402811B2 (en) 2016-08-02
GB201200062D0 (en) 2012-02-15
US20140371191A1 (en) 2014-12-18
EP2800571B1 (en) 2016-09-21
BR112014016510A8 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
LT3725778T (lt) Enzalutamido kompozicijos
FR2997014B1 (fr) Composition sterile dermo-injectable
BR112014032798A2 (pt) composição
EP3488847C0 (en) SEMIFLUORINATED ALKANE COMPOSITIONS
DK2911506T3 (da) Driftreducerende sammensætninger
BR112015002651A2 (pt) composições cosméticas
BR112014028602A2 (pt) formulação líquida.
EP2824167A4 (en) GREASE COMPOSITION
EP2912131A4 (en) Adhesive compositions
EP2803885A4 (en) MIXER
PT2854768T (pt) Composições farmacêuticas de pemetrexed
EP2921549A4 (en) GREASE COMPOSITION
DK2877019T3 (da) Sikkerede herbisidiske sammensætninger til anvendelse i ris
ME03413B (me) Kompozicije које sadrže peg i askorbat
EP2824166A4 (en) GREASE COMPOSITION
EP2934434A4 (en) COSMETIC COMPOSITION
DK2897594T3 (da) Farmaceutisk sammensætning
EP2881431A4 (en) Viscous composition
EP2920370A4 (en) POST
GB201205562D0 (en) Liquid insecticidal compositions
EP2894215A4 (en) FAT COMPOSITION
EP2913045A4 (en) COSMETIC COMPOSITION
BR112014032712A2 (pt) composição
EP2851085A4 (en) STERILIZED COMPOSITION
IL241040A0 (en) Liquid formulations of rascadotril